Introduction Hematologic malignancies, including leukemia, lymphoma, and myeloma, are among the most complex cancers to diagnose and treat due to their diverse genetic and molecular underpinnings. Historically, treatment strategies relied on a one-size-fits-all approach, often leading to suboptimal outcomes and significant side effects. Precision medicine has transformed this landscape, offering a highly personalized approach that […]